EMBO Young Investigator Programme

EMBO Young Investigator Programme
Name	EMBO Young Investigator Programme
Type	Research recognition programme
Established	2000s
Location	Heidelberg
Parent organisation	European Molecular Biology Organization

EMBO Young Investigator Programme

The EMBO Young Investigator Programme is a recognition and support initiative for early-career group leaders in molecular life sciences, established by the European Molecular Biology Organization to foster independent research careers and build networks across Europe and beyond. It provides a combination of prestige, resources, and community linking recipients to institutions, funders, and collaborative platforms in biomedical research. The Programme interacts with universities, research institutes, foundations, and public agencies to amplify the impact of selected investigators on fields such as cell biology, genetics, biochemistry, and systems biology.

Overview

The Programme identifies promising post-PhD group leaders working at institutions such as University of Cambridge, Max Planck Society, Karolinska Institutet, University of Oxford, University of Copenhagen, ETH Zurich, University of Edinburgh, University of Paris, Pasteur Institute, Weizmann Institute of Science, Imperial College London, Utrecht University, University of Zurich, University of Munich, Trinity College Dublin, CNRS, University of Barcelona, University of Geneva, University of Milan, University of Helsinki, University of Bergen, University of Amsterdam, University of Bologna, University of Padua, University of Warsaw, University of Lisbon, University of Porto, Sorbonne University, University of Leeds, University of Manchester, University of Glasgow, University of Sheffield, University of Bristol, University of Liverpool, University of Nottingham, University of Southampton, University of York, University of Liverpool School of Medicine, Queen Mary University of London, University of Antwerp, KU Leuven, Ghent University, University of Freiburg, University of Tübingen, University of Göttingen, RWTH Aachen University, Technical University of Munich, Leibniz Association, EMBL and other leading centres. The selection raises recipients' visibility among funding bodies such as European Research Council, Wellcome Trust, European Molecular Biology Laboratory, Horizon 2020, Horizon Europe, Marie Skłodowska-Curie Actions, National Institutes of Health, Howard Hughes Medical Institute, Gordon and Betty Moore Foundation, Howard Hughes Medical Institute International Research Scholars Program.

Eligibility and Selection

Eligibility criteria typically target early independent group leaders who have held a faculty or equivalent position at institutions like University of Cambridge or Karolinska Institutet for a limited period after starting their independent lab. Selection panels include representatives from organizations such as EMBO, EMBL, European Research Council, Royal Society, Wellcome Trust, Gordon and Betty Moore Foundation, Alexander von Humboldt Foundation, Marie Curie Actions, and senior scientists from institutions such as Max Planck Society, CNRS, University of Oxford, ETH Zurich, Imperial College London, University College London, Sorbonne University, University of Edinburgh, University College Dublin, Trinity College Dublin, Weizmann Institute of Science, Broad Institute, Cold Spring Harbor Laboratory, Sanger Institute, Francis Crick Institute, Karolinska Institutet, KU Leuven, Vrije Universiteit Amsterdam, Ghent University, Leiden University, University of Amsterdam, Technical University of Munich, University of Freiburg. Evaluation considers research output, citations, grants from ERC Starting Grant, ERC Consolidator Grant, Wellcome Investigator Award, NIH R01, awards like the EMBO Gold Medal, Lasker Award, Gairdner Foundation International Award, Breakthrough Prize, and leadership potential demonstrated via collaborations with groups at EMBL-EBI, CERN interdisciplinary initiatives, and networked projects such as Human Cell Atlas, ENCODE Project, Human Genome Project.

Funding and Support

Support often includes modest discretionary funds, networking resources, access to platforms run by EMBL, connections to funders such as European Research Council and Wellcome Trust, and eligibility for additional grants from bodies like Horizon Europe, Marie Skłodowska-Curie Actions, European Regional Development Fund, Bill & Melinda Gates Foundation, Chan Zuckerberg Initiative, Gates Cambridge Scholarship networks, and philanthropic channels including Howard Hughes Medical Institute, Gordon and Betty Moore Foundation, Simons Foundation, King Abdullah University of Science and Technology initiatives. The Programme leverages institutional links to core facilities at institutions such as EMBL, Wellcome Sanger Institute, Francis Crick Institute, Broad Institute, Max Planck Institute for Molecular Biomedicine, MAX IV Laboratory, European Synchrotron Radiation Facility, European Molecular Biology Laboratory, European Laboratory for Particle Physics (CERN) collaborations, and regional infrastructures like ELIXIR, Instruct-ERIC, Euro-BioImaging, LifeTime.

Programme Activities and Mentoring

Activities include networking meetings, retreats, workshops and career development events organized with partners such as EMBL-EBI, Wellcome Genome Campus, Francis Crick Institute, Sanger Institute, Cold Spring Harbor Laboratory, Broad Institute, European Molecular Biology Laboratory', Royal Society, European Research Council, Wellcome Trust, Gordon and Betty Moore Foundation, Marie Curie Actions, European School of Molecular Medicine, FEBS, Gordon Research Conferences, Gordon Research Seminar, Cold Spring Harbor Conferences, Keystone Symposia, EMBL conferences. Mentoring draws on senior scientists affiliated with EMBO, EMBL, Max Planck Society, CNRS, Karolinska Institutet, University of Cambridge, University of Oxford, Harvard University, Stanford University, MIT, Yale University, Princeton University, Columbia University, Johns Hopkins University, University of California, San Francisco, University of California, Berkeley, University of California, San Diego, University of Chicago, Caltech, and industrial partners like Roche, Novartis, AstraZeneca, Pfizer, GlaxoSmithKline, Bayer AG, Sanofi, Boehringer Ingelheim, Merck Group, Genentech, Illumina, Thermo Fisher Scientific.

Impact and Notable Alumni

Alumni of the Programme have progressed to leadership and major awards at institutions including Max Planck Society, University of Cambridge, University of Oxford, ETH Zurich, Karolinska Institutet, Imperial College London, Weizmann Institute of Science, Broad Institute, Sanger Institute, Francis Crick Institute, Harvard University, Stanford University, MIT, Columbia University, Princeton University, Yale University, University of California, San Francisco, University of California, Berkeley, University of California, San Diego, and have secured grants such as ERC Consolidator Grant, Wellcome Trust Investigator Award, NIH R01, and prizes including the EMBO Gold Medal, Royal Society Fellowship, Lasker Award, Gairdner Foundation International Award, Breakthrough Prize, Tang Prize, Nobel Prize-level recognitions through collaborative networks involving Human Genome Project, ENCODE Project, Human Cell Atlas, Cancer Research UK, European Research Council consortia, and translational spin-outs linked to Cambridge Enterprise, Oxford University Innovation, ETH transfer, Karolinska Innovation.

Governance and Administration

The Programme is administered by European Molecular Biology Organization staff in coordination with EMBL administration, advisory boards comprising representatives from EMBO, EMBL, European Research Council, Wellcome Trust, Royal Society, Max Planck Society, CNRS, Karolinska Institutet, University of Cambridge, University of Oxford, ETH Zurich, Imperial College London, KU Leuven, CNIO, Francis Crick Institute, Sanger Institute, and funded through EMBO budgets as well as partnerships with European Commission initiatives such as Horizon Europe, philanthropic donors like Wellcome Trust, Gordon and Betty Moore Foundation, Howard Hughes Medical Institute, and collaborations with national research councils including UK Research and Innovation, Deutsche Forschungsgemeinschaft, Agence Nationale de la Recherche, Vetenskapsrådet, Research Council of Norway, FWO, NWO, Swedish Research Council. Oversight mechanisms include advisory reviews, conflict-of-interest policies aligned with standards from Wellcome Trust, European Research Council, Royal Society, and periodic evaluation linked to metrics used by Leiden Ranking, Times Higher Education World University Rankings, and QS World University Rankings.

Category:European Molecular Biology Organization programs